Cardiovascular autonomic neuropathy contributes to sleep apnea in young and lean type 1 diabetes mellitus patients

被引:27
|
作者
Porto Silva Janovsky, Carolina Castro [1 ]
de Souza Pereira Rolim, Luiz Clemente [1 ]
de Sa, Joao Roberto [1 ]
Poyares, Dalva [2 ]
Tufik, Sergio [2 ]
Silva, Ademir Baptista [3 ]
Dib, Sergio Atala [1 ]
机构
[1] Univ Fed Sao Paulo, Dept Med, Endocrinol & Diabet Div, Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Dept Psychobiol, Sleep Med Div, Sao Paulo, Brazil
[3] Univ Fed Sao Paulo, Neurol & Neurosurg Dept, Clin Neurol Div, Sao Paulo, Brazil
来源
关键词
diabetic autonomic neuropathy; diabetic complications; heart function tests; obstructive sleep apnea; polysomnography; type 1 diabetes mellitus;
D O I
10.3389/fendo.2014.00119
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Knowledge about association between sleep apnea and cardiovascular autonomic neuropathy (CAN) in type 1 diabetes mellitus (T1 DM) might give some insight into the pathogenesis of this condition in these patients. In obese patients, excessive central adiposity, including a large neck circumference, can contribute to obstructive sleep apnea (OSA). Its presence in non-obese patients, however, indicates that it could be correlated with autonomic neuropathy. The aim of this study was to compare the prevalence of OSA in young and lean T1 DM patients with and without CAN. We studied 20 adult, non-obese, T1 DM patients who were divided into two groups according to the results of the cardiovascular autonomic reflex tests (CARTs). These two groups (9 with CAN and 11 without CAN) were compared to a control group of 22 healthy individuals, who were matched by age and BMI. A polysomnography was performed and sleep was analyzed. The CAN+ group had a significantly higher prevalence of sleep apnea compared to the other groups (67% CAN+; 23% CAN-; 4.5% controls: CAN+ vs. Control; p = 0.006 and CAN+ vs. CAN; p = 0.02). The CAN- group had higher sleep efficiency compared to the CAN+ group, demonstrating impaired sleep architecture in diabetics with this chronic complication. In conclusion, OSA may be related to the presence of CAN in young and lean T1 DM patients. It could contribute to worse the prognosis and reducing the quality of life of these patients without specific treatment of these conditions.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Cardiovascular Autonomic Neuropathy and Glucose Variability in Patients With Type 1 Diabetes: Is There an Association?
    Nyiraty, Szabolcs
    Pesei, Fruzsina
    Orosz, Andrea
    Coluzzi, Sara
    Vagi, Orsolya Eszter
    Lengyel, Csaba
    Abraham, Gyorgy
    Frontoni, Simona
    Kempler, Peter
    Varkonyi, Tamas
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [32] Risk factors for diabetic autonomic cardiovascular neuropathy in children and adolescents with type 1 diabetes mellitus
    SHaydullina, M. R.
    Valeeva, F. V.
    YAkupov, E. Z.
    DIABETES MELLITUS, 2013, 16 (03): : 84 - 89
  • [33] Cardiovascular Autonomic Neuropathy in Context of Other Complications of Type 2 Diabetes Mellitus
    Motataianu, Anca
    Balasa, Rodica
    Voidazan, Septimiu
    Bajko, Zoltan
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [34] Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus
    Pafili, Kalliopi
    Trypsianis, Grigorios
    Papazoglou, Dimitrios
    Maltezos, Efstratios
    Papanas, Nikolaos
    DIABETES THERAPY, 2020, 11 (04) : 979 - 986
  • [35] Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus
    Kalliopi Pafili
    Grigorios Trypsianis
    Dimitrios Papazoglou
    Efstratios Maltezos
    Nikolaos Papanas
    Diabetes Therapy, 2020, 11 : 979 - 986
  • [36] Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in asymptomatic normoalbuminuric type 1 diabetes patients
    Mogensen, U. M.
    Jensen, T.
    Kober, L.
    Kelbaek, H.
    Dixen, U.
    Hilsted, J.
    Kofoed, K. F.
    EUROPEAN HEART JOURNAL, 2011, 32 : 845 - 846
  • [37] Inflammatory markers and cardiovascular autonomic neuropathy in type 1 diabetes
    Pop-Busui, R.
    Ang, L.
    Gunaratnam, S.
    Huang, Y.
    Martin, C.
    Burant, A.
    Reis, J.
    Blakely, P.
    Vasbinder, A.
    Zhao, L.
    Mizokami-Stout, K.
    Feldman, E. L.
    Hayek, S.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S366 - S367
  • [38] Inflammatory Markers and Cardiovascular Autonomic Neuropathy in Type 1 Diabetes
    Ang, Lynn
    Gunaratnam, Sejal V. G.
    Huang, Yiyuan
    Mizokami-Stout, Kara R.
    Martin, Catherine
    Reiss, Jacob
    Burant, Aaron
    Vasbinder, Alexi
    Launius, Christopher
    Zhao, Lili
    Feldman, Eva L.
    Hayek, Salim
    Pop-Busui, Rodica
    DIABETES, 2022, 71
  • [39] MORTALITY OF AUTONOMIC CARDIOVASCULAR NEUROPATHY IN DIABETES-MELLITUS
    SALA, JMV
    SAEZ, JMG
    ESTEVE, RI
    HOSSELBARTH, AF
    URIACH, CV
    BERTRAN, MM
    SARDA, AN
    RAMON, JS
    MEDICINA CLINICA, 1983, 81 (18): : 794 - 796
  • [40] Cardiovascular autonomic neuropathy and bone metabolism in Type 1 diabetes
    Hansen, C. S.
    Theilade, S.
    Lajer, M.
    Hansen, T. W.
    Rossing, P.
    DIABETIC MEDICINE, 2018, 35 (11) : 1596 - 1604